Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 1/2012

01-02-2012 | Diabetes and Pregnancy (CJ Homko, Section Editor)

Management of Diabetes in Pregnancy

Authors: Jerasimos Ballas, Thomas R. Moore, Gladys A. Ramos

Published in: Current Diabetes Reports | Issue 1/2012

Login to get access

Abstract

The link between diabetes and poor pregnancy outcomes is well established. As in the non-pregnant population, pregnant women with diabetes can experience profound effects on multiple maternal organ systems. In the fetus, morbidities arising from exposure to diabetes in utero include not only increased congenital anomalies, fetal overgrowth, and stillbirth, but metabolic abnormalities that appear to carry on into early life, adolescence, and beyond. This article emphasizes the newest guidelines for diabetes screening in pregnancy while reviewing their potential impact on maternal and neonatal complications that arise in the setting of hyperglycemia in pregnancy.
Literature
1.
•• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 34 (Suppl 1):S62–69. This updates readers on the classification of and possible etiologies of diabetes mellitus.CrossRef
2.
•• International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3): S76–S82. This is an update on the new recommendations for screening and diagnosing diabetes in pregnancy. It also notes that pregestational diabetes should be diagnosed in the first trimester.CrossRef
3.
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRef
4.
• The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes: associations with neonatal anthropometrics. Diabetes. 2009; 58(2): 453–459. This secondary analysis of the HAPO trial demonstrates the relationship between maternal hyperglycemia and neonatal anthropometric measurements, which adds support to the Pederson hypothesis.CrossRef
5.
Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: a systematic review for the US preventive services task force. Ann Intern Med. 2008;148:766–75.PubMed
6.
Crowther CA, Jiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study Group in Pregnant Women (ACHOIS) trial group, effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–86.PubMedCrossRef
7.
•• Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14): 1139–1148. This randomized control trial demonstrates that treatment of gestational diabetes is associated with lower rates of macrosomia and fat mass in the neonates of mothers with gestational diabetes.CrossRef
8.
Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol. 1991;164:103–11.PubMed
9.
de Veciana M, Trail PA, Evans AT, et al. A comparison of oral acarbose and insulin in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2002;99 Suppl 4:S5.
10.
Parretti E, Mecacci F, Papini M. Third trimester maternal glucose level from diurnal profiles in nondiabetic pregnancies—correlation with sonographic paramertes of fetal growth. Diabetes Care. 2001;24:1317–23.CrossRef
11.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 2007;30:S251–60.PubMedCrossRef
12.
Zucker P, Simon G. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy. Pediatrics. 1968;42:824–5.PubMed
13.
Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995;18:1446–51.PubMedCrossRef
14.
Elliott BD, Schenker S, Langer O, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol. 1994;171:653–60.PubMed
15.
Langer O, Conway D, Berkus M, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134–8.PubMedCrossRef
16.
Chmait R, Dinise T, Daneshmand S, et al. Prospective cohort study to establish predictors of glyburide success in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2001;185:S197.CrossRef
17.
Moore TR. Glyburide for the treatment of gestational diabetes: a critical appraisal. Diabetes Care. 2007;30:S209–13.PubMedCrossRef
18.
Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193:118–24.PubMedCrossRef
19.
Coustan DR. Pharmacological management of gestational diabetes: an overview. Diabetes Care. 2007;30:S206–8.PubMedCrossRef
20.
Hebert MF, Ma X, Naraharesetti SB, Krudys KM, Umans JG, Hankins GDV, Caritis SN, Miodovnik M, et al. Are we optimizing gestational diabetes treatment with Glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85(6):607–14.PubMedCrossRef
21.
Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Eng J Med. 2007;356:551–66.CrossRef
22.
Coetzee EJ, Jackson WP. Metformin in management of pregnant insulin-independent diabetics. Diabetologia. 1979;16:241–5.PubMedCrossRef
23.
Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000;17:507–11.PubMedCrossRef
24.
Hughes RC, Rowan JA. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome? Diabet Med. 2006;23:318–22.PubMedCrossRef
25.
• Rowan J, Hague W, Gao W, Battin M, Moore P. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19): 2003–2015. This discusses the first randomized trial of the use of metformin for the treatment of gestational diabetes.PubMedCrossRef
26.
Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7.PubMedCrossRef
27.
Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol. 2000;182:1283–91.PubMedCrossRef
28.
Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197(5):447–56.PubMedCrossRef
29.
Moore TR, Catalano P. Diabetes in Pregnancy in Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR (Ed.), Creasy and Resnik’s maternal-fetal medicine: principles and practice (6th ed). 2009: 958–967
30.
Landon MB, Catalano PM, Gabbe SG. Diabetes mellitus in Gabbe SG, Niebyl JR, Simpson JL (Ed), Obstetrics, Normal and Problem Pregnancies (4th ed). 2002: 1089–1097.
31.
Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol. 2000;182:364–9.PubMedCrossRef
32.
Sibai BM, Ross MG. Hypertension in gestational diabetes mellitus: pathophysiology and long-term consequences. J Matern-Fetal Neo M. 2010;23(3):229–33.CrossRef
33.
Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res CL OB. 2011;25:77–90.CrossRef
34.
American Diabetes Association. Nephropathy in diabetes—position statement. Diabetes Care. 2004;27(Supp 1):S79–83.
35.
Kitzmiller JL, Block JM, Brown FM, Catalano PM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations. Diabetes Care. 2008;31(5):1060–79.PubMedCrossRef
36.
Jensen DM, Damm P, Ovesen P, Molsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Moeller M, Mathiesen ER. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes. Diabetes Care. 2010;33(1):90–4.PubMedCrossRef
37.
• Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuniuria or diabetic nephropathy – effect of intensified antihypertensive therapy? Diabetes Care. 2009; 32(1): 38–44. This study highlights the importance of meticulous antihypertensive therapy as an adjunct to the treatment of DM1 in pregnancy.PubMedCrossRef
38.
Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev. 2009;5:151–6.PubMedCrossRef
39.
Kollias AN, Ulbig MW. Diabetic retinopathy—early diagnosis and effective treatment. Dtsch Artebl Int. 2010;107(5):75–84.
40.
41.
Cullen MT, Reece EA, Homko CJ, et al. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol. 1996;13:449.PubMedCrossRef
42.
American College of Obstetricians and Gynecologists (ACOG). Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 60: pregestational diabetes mellitus. Obstet Gynecol. 2005;105:675–85.CrossRef
43.
44.
45.
Miller E, Hare JW, Clohert JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL. Elevated hemoglobin A1C in early pregnancy and major congenital anomalies in infants with diabetic mothers. N Engl J Med. 1981;304(22):1331–4.PubMedCrossRef
46.
Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks of specific birth defects: a population-based case–control study. Pediatrics. 1990;85:1–9.PubMed
47.
Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DM, Reece A. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;237:e1–9.
48.
Anderson JL, Waller DM, Canfield MA, Shaw GM, Watkins ML, Werler MM. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology. 2005;16(1):87–92.PubMedCrossRef
49.
Remsberg KE, McKeown RE, McFarland KF, Irwin LS. Diabetes in pregnancy and cesarean delivery. Diabetes Care. 1999;22:1561–7.PubMedCrossRef
50.
Keller JD, Lopez-Zeno JA, Dooley SL, Socol ML. Shoulder dystocia and birth trauma in gestational diabetes: a five-year experience. Am J Obstet Gynecol. 1991;165:928.PubMed
51.
Mimouni F, Miodovnik M, Rosenn B, et al. Birth trauma in insulin-dependent diabetic pregnancies. Am J Perinatol. 1992;9:205–8.PubMedCrossRef
52.
Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998;179:476.PubMedCrossRef
53.
Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.PubMedCrossRef
54.
Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191:964–4.PubMedCrossRef
55.
Ogata ES, Sabbagha R, Metzger BE, et al. Serial ultrasonography to assess evolving fetal macrosomia: studies in 23 pregnant diabetic women. JAMA. 1980;243:2405.PubMedCrossRef
56.
Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698–704.PubMedCrossRef
57.
American College of Obstetricians and Gynecologists (ACOG). Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 40: shoulder dystocia. Obstet Gynecol. 2002;100:1045–50.CrossRef
58.
Kjos SL, Walther FJ, Montoro M, et al. Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive value of fetal lung maturation tests. Am J Obstet Gynecol. 1990;163:898.PubMed
59.
Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641–50.PubMedCrossRef
60.
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–6.PubMedCrossRef
61.
Parretti E, Mecacci F, Panini M, et al. Third trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care. 2001;24:1317.CrossRef
Metadata
Title
Management of Diabetes in Pregnancy
Authors
Jerasimos Ballas
Thomas R. Moore
Gladys A. Ramos
Publication date
01-02-2012
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 1/2012
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-011-0249-0

Other articles of this Issue 1/2012

Current Diabetes Reports 1/2012 Go to the issue

Diabetes and Pregnancy (CJ Homko, Section Editor)

Insulin Pumps in Pregnancy: Using Technology to Achieve Normoglycemia in Women with Diabetes

Hospital Management of Diabetes (M Korytkowski, Section Editor)

Medical Nutrition Therapy in Hospitalized Patients with Diabetes

Invited Commentary

The Adjectives of Inpatient Glycemic Management

Hospital Management of Diabetes (M Korytkowski, Section Editor)

Basal-Bolus Insulin Protocols Enter the Computer Age

Diabetes and Pregnancy (CJ Homko, Section Editor)

Care of the Infant of the Diabetic Mother

Diabetes and Pregnancy (CJ Homko, Section Editor)

Flavor Learning In Utero and Its Implications for Future Obesity and Diabetes
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits